*Result*: Using Smartphone-Based Digital Phenotyping to Predict Relapse in Serious Mental Disorders Among Slum Residents in Dhaka, Bangladesh: Protocol for a Machine Learning Study.
J Med Internet Res. 2023 Dec 13;25:e46778. (PMID: 38090800)
Am J Public Health. 1999 Sep;89(9):1315-8. (PMID: 10474545)
Am J Psychiatry. 2003 Jul;160(7):1209-22. (PMID: 12832232)
J Ment Health. 2024 Aug;33(4):439-442. (PMID: 39301756)
J Med Internet Res. 2021 Mar 10;23(3):e23144. (PMID: 33688835)
Asian J Psychiatr. 2021 Apr;58:102601. (PMID: 33611083)
Neuropsychopharmacology. 2018 Jul;43(8):1660-1666. (PMID: 29511333)
Health Serv Insights. 2017 Mar 28;10:1178632917694350. (PMID: 28469456)
World J Biol Psychiatry. 2009;10(4):269-75. (PMID: 19921968)
JMIR Mhealth Uhealth. 2020 Jul 21;8(7):e16473. (PMID: 32706736)
Schizophr Res. 2014 Feb;152(2-3):408-14. (PMID: 23972821)
Ann Gen Psychiatry. 2010 May 07;9:20. (PMID: 20459646)
Eur Arch Psychiatry Clin Neurosci. 2024 Sep 18;:. (PMID: 39292261)
Health Technol Assess. 2022 May;26(27):1-174. (PMID: 35639493)
JMIR Mhealth Uhealth. 2020 Aug 31;8(8):e19962. (PMID: 32865506)
Psychosomatics. 2010 Nov-Dec;51(6):458-65. (PMID: 21051676)
J Psychiatr Res. 2018 Mar;98:95-98. (PMID: 29331930)
Schizophr Res. 2005 Dec 1;80(1):117-30. (PMID: 15978778)
J Med Internet Res. 2023 Feb 9;25:e39258. (PMID: 36757759)
JMIR Ment Health. 2016 May 05;3(2):e16. (PMID: 27150677)
NPJ Digit Med. 2019 Sep 6;2:88. (PMID: 31508498)
BJPsych Open. 2020 Nov 03;6(6):e135. (PMID: 33138889)
J Am Med Inform Assoc. 2019 Nov 1;26(11):1412-1420. (PMID: 31260049)
Encephale. 2018 Apr;44(2):168-175. (PMID: 29096909)
Lancet. 2012 Jun 2;379(9831):2063-71. (PMID: 22560607)
Front Psychol. 2021 Sep 30;12:692545. (PMID: 34659009)
J Am Coll Health. 2023 Apr;71(3):736-748. (PMID: 33769927)
Schizophrenia (Heidelb). 2023 Jan 27;9(1):6. (PMID: 36707524)
Schizophr Bull. 1987;13(2):261-76. (PMID: 3616518)
J Anxiety Disord. 2024 Oct;107:102925. (PMID: 39270371)
Restor Dent Endod. 2016 Feb;41(1):74-8. (PMID: 26877994)
BMJ Open. 2024 Nov 27;14(11):e091425. (PMID: 39609011)
Ethics Med Public Health. 2021 Dec;19:. (PMID: 35083375)
Soc Sci Med. 1995 Nov;41(10):1403-9. (PMID: 8560308)
BMC Public Health. 2012 Mar 09;12:177. (PMID: 22404959)
BMC Psychiatry. 2014 Jul 30;14:216. (PMID: 25073970)
Indian J Ophthalmol. 2010 Nov-Dec;58(6):517-8. (PMID: 20952836)
Curr Psychiatry Rep. 2023 Nov;25(11):699-706. (PMID: 37861979)
JMIR Form Res. 2025 Jun 23;9:e65530. (PMID: 40549359)
Int J Health Geogr. 2011 May 20;10:36. (PMID: 21599932)
BMJ. 2020 Mar 18;368:m441. (PMID: 32188600)
Mol Psychiatry. 2023 Mar;28(3):974-976. (PMID: 36564488)
J Sleep Res. 2016 Oct;25(5):549-555. (PMID: 27242171)
PLoS One. 2024 Jul 3;19(7):e0305192. (PMID: 38959205)
J Med Internet Res. 2023 Oct 4;25:e44502. (PMID: 37792430)
Transl Psychiatry. 2021 Jan 11;11(1):28. (PMID: 33431818)
BJPsych Open. 2022 Oct 13;8(6):e185. (PMID: 36226591)
Front Psychiatry. 2020 Dec 18;11:584711. (PMID: 33391050)
BMJ Open. 2021 Mar 24;11(3):e045005. (PMID: 33762242)
Commun Med (Lond). 2025 Aug 19;5(1):360. (PMID: 40830260)
Clin Psychol (New York). 2009 Jun;16(2):256-277. (PMID: 22493520)
Philos Technol. 2021;34(4):1905-1928. (PMID: 34786325)
Community Ment Health J. 2016 May;52(4):399-405. (PMID: 26443671)
Sleep Med Clin. 2015 Mar;10(1):101-5. (PMID: 25750600)
J Affect Disord. 2021 Mar 1;282:104-111. (PMID: 33401123)
Br Med Bull. 2007;81-82:81-96. (PMID: 17470476)
IEEE Trans Biomed Eng. 2017 Aug;64(8):1761-1771. (PMID: 28113247)
J Psychiatr Res. 2021 Jun;138:436-443. (PMID: 33964681)
World Psychiatry. 2024 Feb;23(1):58-90. (PMID: 38214615)
NPJ Schizophr. 2020 May 5;6(1):13. (PMID: 32372059)
Neuropsychopharmacology. 2016 Jun;41(7):1691-6. (PMID: 26818126)
Acta Psychiatr Scand. 2025 Mar;151(3):388-400. (PMID: 38807465)
Aust N Z J Psychiatry. 1998 Dec;32(6):815-22. (PMID: 10084346)
Soc Psychiatry Psychiatr Epidemiol. 2025 Oct 31;:. (PMID: 41174073)
*Further Information*
*Background: Serious mental illnesses (SMIs) are associated with high relapse rates and limited access to continuous care, particularly in low-resource settings such as urban slums. Traditional clinical monitoring is constrained by accessibility and scalability challenges. Digital phenotyping, through passive smartphone data, offers a novel approach to predict relapse by capturing real-world behavioral changes.
Objective: This study aims to evaluate the feasibility and predictive value of smartphone-based digital phenotyping for detecting relapse in individuals with SMIs living in the Korail slum of Dhaka, Bangladesh.
Methods: This prospective 6-month cohort study will recruit 430 participants diagnosed with SMIs who own Android (Google LLC) smartphones. Passive data (eg, screen time, mobility, and call or text frequency) will be continuously collected using a custom-built app (DataDoc). Monthly active data, including symptom and functioning assessments, will be collected via self-report and clinical engagement. Machine learning models will integrate these data to detect early warning signs and predict relapse trajectories.
Results: This study was funded by the NIHR (National Institute for Health and Care Research; award number NIHR200846) in October 2022. Data collection commenced in August 2025 and is ongoing. A total of 14 participants have been recruited, as of January 2026. Preliminary data analysis is ongoing, with expected results to be published in fall 2026.
Conclusions: This study is one of the first to apply smartphone-based digital phenotyping and machine learning for relapse prediction in low- and middle-income countries' slum settings. The findings will inform scalable, low-cost digital interventions to address the mental health treatment gap in underresourced communities.
(© Nadia Alam, Chayon Kumar Das, Neelabja Roy, Domenico Giacco, Swaran P Singh, Sagar Jilka. Originally published in JMIR Research Protocols (https://www.researchprotocols.org).)*